Global HIV Therapy Drug Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
According to our (Global Info Research) latest study, the global HIV Therapy Drug market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global HIV Therapy Drug market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global HIV Therapy Drug market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global HIV Therapy Drug market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global HIV Therapy Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global HIV Therapy Drug market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for HIV Therapy Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global HIV Therapy Drug market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ViiV Healthcare, Gilead Sciences, Inc, AbbVie Inc., Merck & Co, GSK, Bristol-Myers Squibb Company, Theratechnologies Inc., Roche Holding AG, Teva Pharmaceuticals, Pfizer, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
HIV Therapy Drug market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe HIV Therapy Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of HIV Therapy Drug, with price, sales quantity, revenue, and global market share of HIV Therapy Drug from 2020 to 2025.
Chapter 3, the HIV Therapy Drug competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the HIV Therapy Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and HIV Therapy Drug market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of HIV Therapy Drug.
Chapter 14 and 15, to describe HIV Therapy Drug sales channel, distributors, customers, research findings and conclusion.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global HIV Therapy Drug market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global HIV Therapy Drug market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global HIV Therapy Drug market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global HIV Therapy Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global HIV Therapy Drug market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for HIV Therapy Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global HIV Therapy Drug market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ViiV Healthcare, Gilead Sciences, Inc, AbbVie Inc., Merck & Co, GSK, Bristol-Myers Squibb Company, Theratechnologies Inc., Roche Holding AG, Teva Pharmaceuticals, Pfizer, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
HIV Therapy Drug market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Multi-Type Combined Drugs
- Nucleoside Reverse Transcription Enzyme Inhibitors
- Non-Nucleoside Reverse Transcription Enzyme Inhibitors
- Hiv Integrated Enzyme Chain Transfer Inhibitor
- Hospital
- Clinic
- Pharmacy
- ViiV Healthcare
- Gilead Sciences, Inc
- AbbVie Inc.
- Merck & Co
- GSK
- Bristol-Myers Squibb Company
- Theratechnologies Inc.
- Roche Holding AG
- Teva Pharmaceuticals
- Pfizer
- Frontier Biotechnologies
- Shionogi
- Janssen Pharmaceuticals, Inc.
- Mylan Pharmaceuticals Inc.
- Genentech, Inc.
- Boehringer Ingelheim
- Cipla
- MSD
- Abbott
- Johnson & Johnson
- Biocon Limited
- Affine Formulations Limited
- IPCA Laboratories
- Natco Pharma
- Beacon Pharmaceuticals
- Julphar Bangladesh
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe HIV Therapy Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of HIV Therapy Drug, with price, sales quantity, revenue, and global market share of HIV Therapy Drug from 2020 to 2025.
Chapter 3, the HIV Therapy Drug competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the HIV Therapy Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and HIV Therapy Drug market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of HIV Therapy Drug.
Chapter 14 and 15, to describe HIV Therapy Drug sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global HIV Therapy Drug Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Multi-Type Combined Drugs
1.3.3 Nucleoside Reverse Transcription Enzyme Inhibitors
1.3.4 Non-Nucleoside Reverse Transcription Enzyme Inhibitors
1.3.5 Hiv Integrated Enzyme Chain Transfer Inhibitor
1.4 Market Analysis by Application
1.4.1 Overview: Global HIV Therapy Drug Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Pharmacy
1.5 Global HIV Therapy Drug Market Size & Forecast
1.5.1 Global HIV Therapy Drug Consumption Value (2020 & 2024 & 2031)
1.5.2 Global HIV Therapy Drug Sales Quantity (2020-2031)
1.5.3 Global HIV Therapy Drug Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 ViiV Healthcare
2.1.1 ViiV Healthcare Details
2.1.2 ViiV Healthcare Major Business
2.1.3 ViiV Healthcare HIV Therapy Drug Product and Services
2.1.4 ViiV Healthcare HIV Therapy Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 ViiV Healthcare Recent Developments/Updates
2.2 Gilead Sciences, Inc
2.2.1 Gilead Sciences, Inc Details
2.2.2 Gilead Sciences, Inc Major Business
2.2.3 Gilead Sciences, Inc HIV Therapy Drug Product and Services
2.2.4 Gilead Sciences, Inc HIV Therapy Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Gilead Sciences, Inc Recent Developments/Updates
2.3 AbbVie Inc.
2.3.1 AbbVie Inc. Details
2.3.2 AbbVie Inc. Major Business
2.3.3 AbbVie Inc. HIV Therapy Drug Product and Services
2.3.4 AbbVie Inc. HIV Therapy Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 AbbVie Inc. Recent Developments/Updates
2.4 Merck & Co
2.4.1 Merck & Co Details
2.4.2 Merck & Co Major Business
2.4.3 Merck & Co HIV Therapy Drug Product and Services
2.4.4 Merck & Co HIV Therapy Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Merck & Co Recent Developments/Updates
2.5 GSK
2.5.1 GSK Details
2.5.2 GSK Major Business
2.5.3 GSK HIV Therapy Drug Product and Services
2.5.4 GSK HIV Therapy Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 GSK Recent Developments/Updates
2.6 Bristol-Myers Squibb Company
2.6.1 Bristol-Myers Squibb Company Details
2.6.2 Bristol-Myers Squibb Company Major Business
2.6.3 Bristol-Myers Squibb Company HIV Therapy Drug Product and Services
2.6.4 Bristol-Myers Squibb Company HIV Therapy Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Bristol-Myers Squibb Company Recent Developments/Updates
2.7 Theratechnologies Inc.
2.7.1 Theratechnologies Inc. Details
2.7.2 Theratechnologies Inc. Major Business
2.7.3 Theratechnologies Inc. HIV Therapy Drug Product and Services
2.7.4 Theratechnologies Inc. HIV Therapy Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Theratechnologies Inc. Recent Developments/Updates
2.8 Roche Holding AG
2.8.1 Roche Holding AG Details
2.8.2 Roche Holding AG Major Business
2.8.3 Roche Holding AG HIV Therapy Drug Product and Services
2.8.4 Roche Holding AG HIV Therapy Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Roche Holding AG Recent Developments/Updates
2.9 Teva Pharmaceuticals
2.9.1 Teva Pharmaceuticals Details
2.9.2 Teva Pharmaceuticals Major Business
2.9.3 Teva Pharmaceuticals HIV Therapy Drug Product and Services
2.9.4 Teva Pharmaceuticals HIV Therapy Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Teva Pharmaceuticals Recent Developments/Updates
2.10 Pfizer
2.10.1 Pfizer Details
2.10.2 Pfizer Major Business
2.10.3 Pfizer HIV Therapy Drug Product and Services
2.10.4 Pfizer HIV Therapy Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Pfizer Recent Developments/Updates
2.11 Frontier Biotechnologies
2.11.1 Frontier Biotechnologies Details
2.11.2 Frontier Biotechnologies Major Business
2.11.3 Frontier Biotechnologies HIV Therapy Drug Product and Services
2.11.4 Frontier Biotechnologies HIV Therapy Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Frontier Biotechnologies Recent Developments/Updates
2.12 Shionogi
2.12.1 Shionogi Details
2.12.2 Shionogi Major Business
2.12.3 Shionogi HIV Therapy Drug Product and Services
2.12.4 Shionogi HIV Therapy Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Shionogi Recent Developments/Updates
2.13 Janssen Pharmaceuticals, Inc.
2.13.1 Janssen Pharmaceuticals, Inc. Details
2.13.2 Janssen Pharmaceuticals, Inc. Major Business
2.13.3 Janssen Pharmaceuticals, Inc. HIV Therapy Drug Product and Services
2.13.4 Janssen Pharmaceuticals, Inc. HIV Therapy Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Janssen Pharmaceuticals, Inc. Recent Developments/Updates
2.14 Mylan Pharmaceuticals Inc.
2.14.1 Mylan Pharmaceuticals Inc. Details
2.14.2 Mylan Pharmaceuticals Inc. Major Business
2.14.3 Mylan Pharmaceuticals Inc. HIV Therapy Drug Product and Services
2.14.4 Mylan Pharmaceuticals Inc. HIV Therapy Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Mylan Pharmaceuticals Inc. Recent Developments/Updates
2.15 Genentech, Inc.
2.15.1 Genentech, Inc. Details
2.15.2 Genentech, Inc. Major Business
2.15.3 Genentech, Inc. HIV Therapy Drug Product and Services
2.15.4 Genentech, Inc. HIV Therapy Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 Genentech, Inc. Recent Developments/Updates
2.16 Boehringer Ingelheim
2.16.1 Boehringer Ingelheim Details
2.16.2 Boehringer Ingelheim Major Business
2.16.3 Boehringer Ingelheim HIV Therapy Drug Product and Services
2.16.4 Boehringer Ingelheim HIV Therapy Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.16.5 Boehringer Ingelheim Recent Developments/Updates
2.17 Cipla
2.17.1 Cipla Details
2.17.2 Cipla Major Business
2.17.3 Cipla HIV Therapy Drug Product and Services
2.17.4 Cipla HIV Therapy Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.17.5 Cipla Recent Developments/Updates
2.18 MSD
2.18.1 MSD Details
2.18.2 MSD Major Business
2.18.3 MSD HIV Therapy Drug Product and Services
2.18.4 MSD HIV Therapy Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.18.5 MSD Recent Developments/Updates
2.19 Abbott
2.19.1 Abbott Details
2.19.2 Abbott Major Business
2.19.3 Abbott HIV Therapy Drug Product and Services
2.19.4 Abbott HIV Therapy Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.19.5 Abbott Recent Developments/Updates
2.20 Johnson & Johnson
2.20.1 Johnson & Johnson Details
2.20.2 Johnson & Johnson Major Business
2.20.3 Johnson & Johnson HIV Therapy Drug Product and Services
2.20.4 Johnson & Johnson HIV Therapy Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.20.5 Johnson & Johnson Recent Developments/Updates
2.21 Biocon Limited
2.21.1 Biocon Limited Details
2.21.2 Biocon Limited Major Business
2.21.3 Biocon Limited HIV Therapy Drug Product and Services
2.21.4 Biocon Limited HIV Therapy Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.21.5 Biocon Limited Recent Developments/Updates
2.22 Affine Formulations Limited
2.22.1 Affine Formulations Limited Details
2.22.2 Affine Formulations Limited Major Business
2.22.3 Affine Formulations Limited HIV Therapy Drug Product and Services
2.22.4 Affine Formulations Limited HIV Therapy Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.22.5 Affine Formulations Limited Recent Developments/Updates
2.23 IPCA Laboratories
2.23.1 IPCA Laboratories Details
2.23.2 IPCA Laboratories Major Business
2.23.3 IPCA Laboratories HIV Therapy Drug Product and Services
2.23.4 IPCA Laboratories HIV Therapy Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.23.5 IPCA Laboratories Recent Developments/Updates
2.24 Natco Pharma
2.24.1 Natco Pharma Details
2.24.2 Natco Pharma Major Business
2.24.3 Natco Pharma HIV Therapy Drug Product and Services
2.24.4 Natco Pharma HIV Therapy Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.24.5 Natco Pharma Recent Developments/Updates
2.25 Beacon Pharmaceuticals
2.25.1 Beacon Pharmaceuticals Details
2.25.2 Beacon Pharmaceuticals Major Business
2.25.3 Beacon Pharmaceuticals HIV Therapy Drug Product and Services
2.25.4 Beacon Pharmaceuticals HIV Therapy Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.25.5 Beacon Pharmaceuticals Recent Developments/Updates
2.26 Julphar Bangladesh
2.26.1 Julphar Bangladesh Details
2.26.2 Julphar Bangladesh Major Business
2.26.3 Julphar Bangladesh HIV Therapy Drug Product and Services
2.26.4 Julphar Bangladesh HIV Therapy Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.26.5 Julphar Bangladesh Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: HIV THERAPY DRUG BY MANUFACTURER
3.1 Global HIV Therapy Drug Sales Quantity by Manufacturer (2020-2025)
3.2 Global HIV Therapy Drug Revenue by Manufacturer (2020-2025)
3.3 Global HIV Therapy Drug Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of HIV Therapy Drug by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 HIV Therapy Drug Manufacturer Market Share in 2024
3.4.3 Top 6 HIV Therapy Drug Manufacturer Market Share in 2024
3.5 HIV Therapy Drug Market: Overall Company Footprint Analysis
3.5.1 HIV Therapy Drug Market: Region Footprint
3.5.2 HIV Therapy Drug Market: Company Product Type Footprint
3.5.3 HIV Therapy Drug Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global HIV Therapy Drug Market Size by Region
4.1.1 Global HIV Therapy Drug Sales Quantity by Region (2020-2031)
4.1.2 Global HIV Therapy Drug Consumption Value by Region (2020-2031)
4.1.3 Global HIV Therapy Drug Average Price by Region (2020-2031)
4.2 North America HIV Therapy Drug Consumption Value (2020-2031)
4.3 Europe HIV Therapy Drug Consumption Value (2020-2031)
4.4 Asia-Pacific HIV Therapy Drug Consumption Value (2020-2031)
4.5 South America HIV Therapy Drug Consumption Value (2020-2031)
4.6 Middle East & Africa HIV Therapy Drug Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global HIV Therapy Drug Sales Quantity by Type (2020-2031)
5.2 Global HIV Therapy Drug Consumption Value by Type (2020-2031)
5.3 Global HIV Therapy Drug Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global HIV Therapy Drug Sales Quantity by Application (2020-2031)
6.2 Global HIV Therapy Drug Consumption Value by Application (2020-2031)
6.3 Global HIV Therapy Drug Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America HIV Therapy Drug Sales Quantity by Type (2020-2031)
7.2 North America HIV Therapy Drug Sales Quantity by Application (2020-2031)
7.3 North America HIV Therapy Drug Market Size by Country
7.3.1 North America HIV Therapy Drug Sales Quantity by Country (2020-2031)
7.3.2 North America HIV Therapy Drug Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe HIV Therapy Drug Sales Quantity by Type (2020-2031)
8.2 Europe HIV Therapy Drug Sales Quantity by Application (2020-2031)
8.3 Europe HIV Therapy Drug Market Size by Country
8.3.1 Europe HIV Therapy Drug Sales Quantity by Country (2020-2031)
8.3.2 Europe HIV Therapy Drug Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific HIV Therapy Drug Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific HIV Therapy Drug Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific HIV Therapy Drug Market Size by Region
9.3.1 Asia-Pacific HIV Therapy Drug Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific HIV Therapy Drug Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America HIV Therapy Drug Sales Quantity by Type (2020-2031)
10.2 South America HIV Therapy Drug Sales Quantity by Application (2020-2031)
10.3 South America HIV Therapy Drug Market Size by Country
10.3.1 South America HIV Therapy Drug Sales Quantity by Country (2020-2031)
10.3.2 South America HIV Therapy Drug Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa HIV Therapy Drug Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa HIV Therapy Drug Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa HIV Therapy Drug Market Size by Country
11.3.1 Middle East & Africa HIV Therapy Drug Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa HIV Therapy Drug Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 HIV Therapy Drug Market Drivers
12.2 HIV Therapy Drug Market Restraints
12.3 HIV Therapy Drug Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of HIV Therapy Drug and Key Manufacturers
13.2 Manufacturing Costs Percentage of HIV Therapy Drug
13.3 HIV Therapy Drug Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 HIV Therapy Drug Typical Distributors
14.3 HIV Therapy Drug Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global HIV Therapy Drug Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Multi-Type Combined Drugs
1.3.3 Nucleoside Reverse Transcription Enzyme Inhibitors
1.3.4 Non-Nucleoside Reverse Transcription Enzyme Inhibitors
1.3.5 Hiv Integrated Enzyme Chain Transfer Inhibitor
1.4 Market Analysis by Application
1.4.1 Overview: Global HIV Therapy Drug Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Pharmacy
1.5 Global HIV Therapy Drug Market Size & Forecast
1.5.1 Global HIV Therapy Drug Consumption Value (2020 & 2024 & 2031)
1.5.2 Global HIV Therapy Drug Sales Quantity (2020-2031)
1.5.3 Global HIV Therapy Drug Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 ViiV Healthcare
2.1.1 ViiV Healthcare Details
2.1.2 ViiV Healthcare Major Business
2.1.3 ViiV Healthcare HIV Therapy Drug Product and Services
2.1.4 ViiV Healthcare HIV Therapy Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 ViiV Healthcare Recent Developments/Updates
2.2 Gilead Sciences, Inc
2.2.1 Gilead Sciences, Inc Details
2.2.2 Gilead Sciences, Inc Major Business
2.2.3 Gilead Sciences, Inc HIV Therapy Drug Product and Services
2.2.4 Gilead Sciences, Inc HIV Therapy Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Gilead Sciences, Inc Recent Developments/Updates
2.3 AbbVie Inc.
2.3.1 AbbVie Inc. Details
2.3.2 AbbVie Inc. Major Business
2.3.3 AbbVie Inc. HIV Therapy Drug Product and Services
2.3.4 AbbVie Inc. HIV Therapy Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 AbbVie Inc. Recent Developments/Updates
2.4 Merck & Co
2.4.1 Merck & Co Details
2.4.2 Merck & Co Major Business
2.4.3 Merck & Co HIV Therapy Drug Product and Services
2.4.4 Merck & Co HIV Therapy Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Merck & Co Recent Developments/Updates
2.5 GSK
2.5.1 GSK Details
2.5.2 GSK Major Business
2.5.3 GSK HIV Therapy Drug Product and Services
2.5.4 GSK HIV Therapy Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 GSK Recent Developments/Updates
2.6 Bristol-Myers Squibb Company
2.6.1 Bristol-Myers Squibb Company Details
2.6.2 Bristol-Myers Squibb Company Major Business
2.6.3 Bristol-Myers Squibb Company HIV Therapy Drug Product and Services
2.6.4 Bristol-Myers Squibb Company HIV Therapy Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Bristol-Myers Squibb Company Recent Developments/Updates
2.7 Theratechnologies Inc.
2.7.1 Theratechnologies Inc. Details
2.7.2 Theratechnologies Inc. Major Business
2.7.3 Theratechnologies Inc. HIV Therapy Drug Product and Services
2.7.4 Theratechnologies Inc. HIV Therapy Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Theratechnologies Inc. Recent Developments/Updates
2.8 Roche Holding AG
2.8.1 Roche Holding AG Details
2.8.2 Roche Holding AG Major Business
2.8.3 Roche Holding AG HIV Therapy Drug Product and Services
2.8.4 Roche Holding AG HIV Therapy Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Roche Holding AG Recent Developments/Updates
2.9 Teva Pharmaceuticals
2.9.1 Teva Pharmaceuticals Details
2.9.2 Teva Pharmaceuticals Major Business
2.9.3 Teva Pharmaceuticals HIV Therapy Drug Product and Services
2.9.4 Teva Pharmaceuticals HIV Therapy Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Teva Pharmaceuticals Recent Developments/Updates
2.10 Pfizer
2.10.1 Pfizer Details
2.10.2 Pfizer Major Business
2.10.3 Pfizer HIV Therapy Drug Product and Services
2.10.4 Pfizer HIV Therapy Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Pfizer Recent Developments/Updates
2.11 Frontier Biotechnologies
2.11.1 Frontier Biotechnologies Details
2.11.2 Frontier Biotechnologies Major Business
2.11.3 Frontier Biotechnologies HIV Therapy Drug Product and Services
2.11.4 Frontier Biotechnologies HIV Therapy Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Frontier Biotechnologies Recent Developments/Updates
2.12 Shionogi
2.12.1 Shionogi Details
2.12.2 Shionogi Major Business
2.12.3 Shionogi HIV Therapy Drug Product and Services
2.12.4 Shionogi HIV Therapy Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Shionogi Recent Developments/Updates
2.13 Janssen Pharmaceuticals, Inc.
2.13.1 Janssen Pharmaceuticals, Inc. Details
2.13.2 Janssen Pharmaceuticals, Inc. Major Business
2.13.3 Janssen Pharmaceuticals, Inc. HIV Therapy Drug Product and Services
2.13.4 Janssen Pharmaceuticals, Inc. HIV Therapy Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Janssen Pharmaceuticals, Inc. Recent Developments/Updates
2.14 Mylan Pharmaceuticals Inc.
2.14.1 Mylan Pharmaceuticals Inc. Details
2.14.2 Mylan Pharmaceuticals Inc. Major Business
2.14.3 Mylan Pharmaceuticals Inc. HIV Therapy Drug Product and Services
2.14.4 Mylan Pharmaceuticals Inc. HIV Therapy Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Mylan Pharmaceuticals Inc. Recent Developments/Updates
2.15 Genentech, Inc.
2.15.1 Genentech, Inc. Details
2.15.2 Genentech, Inc. Major Business
2.15.3 Genentech, Inc. HIV Therapy Drug Product and Services
2.15.4 Genentech, Inc. HIV Therapy Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 Genentech, Inc. Recent Developments/Updates
2.16 Boehringer Ingelheim
2.16.1 Boehringer Ingelheim Details
2.16.2 Boehringer Ingelheim Major Business
2.16.3 Boehringer Ingelheim HIV Therapy Drug Product and Services
2.16.4 Boehringer Ingelheim HIV Therapy Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.16.5 Boehringer Ingelheim Recent Developments/Updates
2.17 Cipla
2.17.1 Cipla Details
2.17.2 Cipla Major Business
2.17.3 Cipla HIV Therapy Drug Product and Services
2.17.4 Cipla HIV Therapy Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.17.5 Cipla Recent Developments/Updates
2.18 MSD
2.18.1 MSD Details
2.18.2 MSD Major Business
2.18.3 MSD HIV Therapy Drug Product and Services
2.18.4 MSD HIV Therapy Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.18.5 MSD Recent Developments/Updates
2.19 Abbott
2.19.1 Abbott Details
2.19.2 Abbott Major Business
2.19.3 Abbott HIV Therapy Drug Product and Services
2.19.4 Abbott HIV Therapy Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.19.5 Abbott Recent Developments/Updates
2.20 Johnson & Johnson
2.20.1 Johnson & Johnson Details
2.20.2 Johnson & Johnson Major Business
2.20.3 Johnson & Johnson HIV Therapy Drug Product and Services
2.20.4 Johnson & Johnson HIV Therapy Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.20.5 Johnson & Johnson Recent Developments/Updates
2.21 Biocon Limited
2.21.1 Biocon Limited Details
2.21.2 Biocon Limited Major Business
2.21.3 Biocon Limited HIV Therapy Drug Product and Services
2.21.4 Biocon Limited HIV Therapy Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.21.5 Biocon Limited Recent Developments/Updates
2.22 Affine Formulations Limited
2.22.1 Affine Formulations Limited Details
2.22.2 Affine Formulations Limited Major Business
2.22.3 Affine Formulations Limited HIV Therapy Drug Product and Services
2.22.4 Affine Formulations Limited HIV Therapy Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.22.5 Affine Formulations Limited Recent Developments/Updates
2.23 IPCA Laboratories
2.23.1 IPCA Laboratories Details
2.23.2 IPCA Laboratories Major Business
2.23.3 IPCA Laboratories HIV Therapy Drug Product and Services
2.23.4 IPCA Laboratories HIV Therapy Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.23.5 IPCA Laboratories Recent Developments/Updates
2.24 Natco Pharma
2.24.1 Natco Pharma Details
2.24.2 Natco Pharma Major Business
2.24.3 Natco Pharma HIV Therapy Drug Product and Services
2.24.4 Natco Pharma HIV Therapy Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.24.5 Natco Pharma Recent Developments/Updates
2.25 Beacon Pharmaceuticals
2.25.1 Beacon Pharmaceuticals Details
2.25.2 Beacon Pharmaceuticals Major Business
2.25.3 Beacon Pharmaceuticals HIV Therapy Drug Product and Services
2.25.4 Beacon Pharmaceuticals HIV Therapy Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.25.5 Beacon Pharmaceuticals Recent Developments/Updates
2.26 Julphar Bangladesh
2.26.1 Julphar Bangladesh Details
2.26.2 Julphar Bangladesh Major Business
2.26.3 Julphar Bangladesh HIV Therapy Drug Product and Services
2.26.4 Julphar Bangladesh HIV Therapy Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.26.5 Julphar Bangladesh Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: HIV THERAPY DRUG BY MANUFACTURER
3.1 Global HIV Therapy Drug Sales Quantity by Manufacturer (2020-2025)
3.2 Global HIV Therapy Drug Revenue by Manufacturer (2020-2025)
3.3 Global HIV Therapy Drug Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of HIV Therapy Drug by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 HIV Therapy Drug Manufacturer Market Share in 2024
3.4.3 Top 6 HIV Therapy Drug Manufacturer Market Share in 2024
3.5 HIV Therapy Drug Market: Overall Company Footprint Analysis
3.5.1 HIV Therapy Drug Market: Region Footprint
3.5.2 HIV Therapy Drug Market: Company Product Type Footprint
3.5.3 HIV Therapy Drug Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global HIV Therapy Drug Market Size by Region
4.1.1 Global HIV Therapy Drug Sales Quantity by Region (2020-2031)
4.1.2 Global HIV Therapy Drug Consumption Value by Region (2020-2031)
4.1.3 Global HIV Therapy Drug Average Price by Region (2020-2031)
4.2 North America HIV Therapy Drug Consumption Value (2020-2031)
4.3 Europe HIV Therapy Drug Consumption Value (2020-2031)
4.4 Asia-Pacific HIV Therapy Drug Consumption Value (2020-2031)
4.5 South America HIV Therapy Drug Consumption Value (2020-2031)
4.6 Middle East & Africa HIV Therapy Drug Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global HIV Therapy Drug Sales Quantity by Type (2020-2031)
5.2 Global HIV Therapy Drug Consumption Value by Type (2020-2031)
5.3 Global HIV Therapy Drug Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global HIV Therapy Drug Sales Quantity by Application (2020-2031)
6.2 Global HIV Therapy Drug Consumption Value by Application (2020-2031)
6.3 Global HIV Therapy Drug Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America HIV Therapy Drug Sales Quantity by Type (2020-2031)
7.2 North America HIV Therapy Drug Sales Quantity by Application (2020-2031)
7.3 North America HIV Therapy Drug Market Size by Country
7.3.1 North America HIV Therapy Drug Sales Quantity by Country (2020-2031)
7.3.2 North America HIV Therapy Drug Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe HIV Therapy Drug Sales Quantity by Type (2020-2031)
8.2 Europe HIV Therapy Drug Sales Quantity by Application (2020-2031)
8.3 Europe HIV Therapy Drug Market Size by Country
8.3.1 Europe HIV Therapy Drug Sales Quantity by Country (2020-2031)
8.3.2 Europe HIV Therapy Drug Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific HIV Therapy Drug Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific HIV Therapy Drug Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific HIV Therapy Drug Market Size by Region
9.3.1 Asia-Pacific HIV Therapy Drug Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific HIV Therapy Drug Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America HIV Therapy Drug Sales Quantity by Type (2020-2031)
10.2 South America HIV Therapy Drug Sales Quantity by Application (2020-2031)
10.3 South America HIV Therapy Drug Market Size by Country
10.3.1 South America HIV Therapy Drug Sales Quantity by Country (2020-2031)
10.3.2 South America HIV Therapy Drug Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa HIV Therapy Drug Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa HIV Therapy Drug Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa HIV Therapy Drug Market Size by Country
11.3.1 Middle East & Africa HIV Therapy Drug Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa HIV Therapy Drug Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 HIV Therapy Drug Market Drivers
12.2 HIV Therapy Drug Market Restraints
12.3 HIV Therapy Drug Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of HIV Therapy Drug and Key Manufacturers
13.2 Manufacturing Costs Percentage of HIV Therapy Drug
13.3 HIV Therapy Drug Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 HIV Therapy Drug Typical Distributors
14.3 HIV Therapy Drug Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF FIGURES
Table 1. Global HIV Therapy Drug Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global HIV Therapy Drug Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. ViiV Healthcare Basic Information, Manufacturing Base and Competitors
Table 4. ViiV Healthcare Major Business
Table 5. ViiV Healthcare HIV Therapy Drug Product and Services
Table 6. ViiV Healthcare HIV Therapy Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. ViiV Healthcare Recent Developments/Updates
Table 8. Gilead Sciences, Inc Basic Information, Manufacturing Base and Competitors
Table 9. Gilead Sciences, Inc Major Business
Table 10. Gilead Sciences, Inc HIV Therapy Drug Product and Services
Table 11. Gilead Sciences, Inc HIV Therapy Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. Gilead Sciences, Inc Recent Developments/Updates
Table 13. AbbVie Inc. Basic Information, Manufacturing Base and Competitors
Table 14. AbbVie Inc. Major Business
Table 15. AbbVie Inc. HIV Therapy Drug Product and Services
Table 16. AbbVie Inc. HIV Therapy Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. AbbVie Inc. Recent Developments/Updates
Table 18. Merck & Co Basic Information, Manufacturing Base and Competitors
Table 19. Merck & Co Major Business
Table 20. Merck & Co HIV Therapy Drug Product and Services
Table 21. Merck & Co HIV Therapy Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. Merck & Co Recent Developments/Updates
Table 23. GSK Basic Information, Manufacturing Base and Competitors
Table 24. GSK Major Business
Table 25. GSK HIV Therapy Drug Product and Services
Table 26. GSK HIV Therapy Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. GSK Recent Developments/Updates
Table 28. Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table 29. Bristol-Myers Squibb Company Major Business
Table 30. Bristol-Myers Squibb Company HIV Therapy Drug Product and Services
Table 31. Bristol-Myers Squibb Company HIV Therapy Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. Bristol-Myers Squibb Company Recent Developments/Updates
Table 33. Theratechnologies Inc. Basic Information, Manufacturing Base and Competitors
Table 34. Theratechnologies Inc. Major Business
Table 35. Theratechnologies Inc. HIV Therapy Drug Product and Services
Table 36. Theratechnologies Inc. HIV Therapy Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 37. Theratechnologies Inc. Recent Developments/Updates
Table 38. Roche Holding AG Basic Information, Manufacturing Base and Competitors
Table 39. Roche Holding AG Major Business
Table 40. Roche Holding AG HIV Therapy Drug Product and Services
Table 41. Roche Holding AG HIV Therapy Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 42. Roche Holding AG Recent Developments/Updates
Table 43. Teva Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 44. Teva Pharmaceuticals Major Business
Table 45. Teva Pharmaceuticals HIV Therapy Drug Product and Services
Table 46. Teva Pharmaceuticals HIV Therapy Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 47. Teva Pharmaceuticals Recent Developments/Updates
Table 48. Pfizer Basic Information, Manufacturing Base and Competitors
Table 49. Pfizer Major Business
Table 50. Pfizer HIV Therapy Drug Product and Services
Table 51. Pfizer HIV Therapy Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 52. Pfizer Recent Developments/Updates
Table 53. Frontier Biotechnologies Basic Information, Manufacturing Base and Competitors
Table 54. Frontier Biotechnologies Major Business
Table 55. Frontier Biotechnologies HIV Therapy Drug Product and Services
Table 56. Frontier Biotechnologies HIV Therapy Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 57. Frontier Biotechnologies Recent Developments/Updates
Table 58. Shionogi Basic Information, Manufacturing Base and Competitors
Table 59. Shionogi Major Business
Table 60. Shionogi HIV Therapy Drug Product and Services
Table 61. Shionogi HIV Therapy Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 62. Shionogi Recent Developments/Updates
Table 63. Janssen Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 64. Janssen Pharmaceuticals, Inc. Major Business
Table 65. Janssen Pharmaceuticals, Inc. HIV Therapy Drug Product and Services
Table 66. Janssen Pharmaceuticals, Inc. HIV Therapy Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 67. Janssen Pharmaceuticals, Inc. Recent Developments/Updates
Table 68. Mylan Pharmaceuticals Inc. Basic Information, Manufacturing Base and Competitors
Table 69. Mylan Pharmaceuticals Inc. Major Business
Table 70. Mylan Pharmaceuticals Inc. HIV Therapy Drug Product and Services
Table 71. Mylan Pharmaceuticals Inc. HIV Therapy Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 72. Mylan Pharmaceuticals Inc. Recent Developments/Updates
Table 73. Genentech, Inc. Basic Information, Manufacturing Base and Competitors
Table 74. Genentech, Inc. Major Business
Table 75. Genentech, Inc. HIV Therapy Drug Product and Services
Table 76. Genentech, Inc. HIV Therapy Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 77. Genentech, Inc. Recent Developments/Updates
Table 78. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 79. Boehringer Ingelheim Major Business
Table 80. Boehringer Ingelheim HIV Therapy Drug Product and Services
Table 81. Boehringer Ingelheim HIV Therapy Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 82. Boehringer Ingelheim Recent Developments/Updates
Table 83. Cipla Basic Information, Manufacturing Base and Competitors
Table 84. Cipla Major Business
Table 85. Cipla HIV Therapy Drug Product and Services
Table 86. Cipla HIV Therapy Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 87. Cipla Recent Developments/Updates
Table 88. MSD Basic Information, Manufacturing Base and Competitors
Table 89. MSD Major Business
Table 90. MSD HIV Therapy Drug Product and Services
Table 91. MSD HIV Therapy Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 92. MSD Recent Developments/Updates
Table 93. Abbott Basic Information, Manufacturing Base and Competitors
Table 94. Abbott Major Business
Table 95. Abbott HIV Therapy Drug Product and Services
Table 96. Abbott HIV Therapy Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 97. Abbott Recent Developments/Updates
Table 98. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 99. Johnson & Johnson Major Business
Table 100. Johnson & Johnson HIV Therapy Drug Product and Services
Table 101. Johnson & Johnson HIV Therapy Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 102. Johnson & Johnson Recent Developments/Updates
Table 103. Biocon Limited Basic Information, Manufacturing Base and Competitors
Table 104. Biocon Limited Major Business
Table 105. Biocon Limited HIV Therapy Drug Product and Services
Table 106. Biocon Limited HIV Therapy Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 107. Biocon Limited Recent Developments/Updates
Table 108. Affine Formulations Limited Basic Information, Manufacturing Base and Competitors
Table 109. Affine Formulations Limited Major Business
Table 110. Affine Formulations Limited HIV Therapy Drug Product and Services
Table 111. Affine Formulations Limited HIV Therapy Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 112. Affine Formulations Limited Recent Developments/Updates
Table 113. IPCA Laboratories Basic Information, Manufacturing Base and Competitors
Table 114. IPCA Laboratories Major Business
Table 115. IPCA Laboratories HIV Therapy Drug Product and Services
Table 116. IPCA Laboratories HIV Therapy Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 117. IPCA Laboratories Recent Developments/Updates
Table 118. Natco Pharma Basic Information, Manufacturing Base and Competitors
Table 119. Natco Pharma Major Business
Table 120. Natco Pharma HIV Therapy Drug Product and Services
Table 121. Natco Pharma HIV Therapy Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 122. Natco Pharma Recent Developments/Updates
Table 123. Beacon Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 124. Beacon Pharmaceuticals Major Business
Table 125. Beacon Pharmaceuticals HIV Therapy Drug Product and Services
Table 126. Beacon Pharmaceuticals HIV Therapy Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 127. Beacon Pharmaceuticals Recent Developments/Updates
Table 128. Julphar Bangladesh Basic Information, Manufacturing Base and Competitors
Table 129. Julphar Bangladesh Major Business
Table 130. Julphar Bangladesh HIV Therapy Drug Product and Services
Table 131. Julphar Bangladesh HIV Therapy Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 132. Julphar Bangladesh Recent Developments/Updates
Table 133. Global HIV Therapy Drug Sales Quantity by Manufacturer (2020-2025) & (K Units)
Table 134. Global HIV Therapy Drug Revenue by Manufacturer (2020-2025) & (USD Million)
Table 135. Global HIV Therapy Drug Average Price by Manufacturer (2020-2025) & (US$/Unit)
Table 136. Market Position of Manufacturers in HIV Therapy Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 137. Head Office and HIV Therapy Drug Production Site of Key Manufacturer
Table 138. HIV Therapy Drug Market: Company Product Type Footprint
Table 139. HIV Therapy Drug Market: Company Product Application Footprint
Table 140. HIV Therapy Drug New Market Entrants and Barriers to Market Entry
Table 141. HIV Therapy Drug Mergers, Acquisition, Agreements, and Collaborations
Table 142. Global HIV Therapy Drug Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 143. Global HIV Therapy Drug Sales Quantity by Region (2020-2025) & (K Units)
Table 144. Global HIV Therapy Drug Sales Quantity by Region (2026-2031) & (K Units)
Table 145. Global HIV Therapy Drug Consumption Value by Region (2020-2025) & (USD Million)
Table 146. Global HIV Therapy Drug Consumption Value by Region (2026-2031) & (USD Million)
Table 147. Global HIV Therapy Drug Average Price by Region (2020-2025) & (US$/Unit)
Table 148. Global HIV Therapy Drug Average Price by Region (2026-2031) & (US$/Unit)
Table 149. Global HIV Therapy Drug Sales Quantity by Type (2020-2025) & (K Units)
Table 150. Global HIV Therapy Drug Sales Quantity by Type (2026-2031) & (K Units)
Table 151. Global HIV Therapy Drug Consumption Value by Type (2020-2025) & (USD Million)
Table 152. Global HIV Therapy Drug Consumption Value by Type (2026-2031) & (USD Million)
Table 153. Global HIV Therapy Drug Average Price by Type (2020-2025) & (US$/Unit)
Table 154. Global HIV Therapy Drug Average Price by Type (2026-2031) & (US$/Unit)
Table 155. Global HIV Therapy Drug Sales Quantity by Application (2020-2025) & (K Units)
Table 156. Global HIV Therapy Drug Sales Quantity by Application (2026-2031) & (K Units)
Table 157. Global HIV Therapy Drug Consumption Value by Application (2020-2025) & (USD Million)
Table 158. Global HIV Therapy Drug Consumption Value by Application (2026-2031) & (USD Million)
Table 159. Global HIV Therapy Drug Average Price by Application (2020-2025) & (US$/Unit)
Table 160. Global HIV Therapy Drug Average Price by Application (2026-2031) & (US$/Unit)
Table 161. North America HIV Therapy Drug Sales Quantity by Type (2020-2025) & (K Units)
Table 162. North America HIV Therapy Drug Sales Quantity by Type (2026-2031) & (K Units)
Table 163. North America HIV Therapy Drug Sales Quantity by Application (2020-2025) & (K Units)
Table 164. North America HIV Therapy Drug Sales Quantity by Application (2026-2031) & (K Units)
Table 165. North America HIV Therapy Drug Sales Quantity by Country (2020-2025) & (K Units)
Table 166. North America HIV Therapy Drug Sales Quantity by Country (2026-2031) & (K Units)
Table 167. North America HIV Therapy Drug Consumption Value by Country (2020-2025) & (USD Million)
Table 168. North America HIV Therapy Drug Consumption Value by Country (2026-2031) & (USD Million)
Table 169. Europe HIV Therapy Drug Sales Quantity by Type (2020-2025) & (K Units)
Table 170. Europe HIV Therapy Drug Sales Quantity by Type (2026-2031) & (K Units)
Table 171. Europe HIV Therapy Drug Sales Quantity by Application (2020-2025) & (K Units)
Table 172. Europe HIV Therapy Drug Sales Quantity by Application (2026-2031) & (K Units)
Table 173. Europe HIV Therapy Drug Sales Quantity by Country (2020-2025) & (K Units)
Table 174. Europe HIV Therapy Drug Sales Quantity by Country (2026-2031) & (K Units)
Table 175. Europe HIV Therapy Drug Consumption Value by Country (2020-2025) & (USD Million)
Table 176. Europe HIV Therapy Drug Consumption Value by Country (2026-2031) & (USD Million)
Table 177. Asia-Pacific HIV Therapy Drug Sales Quantity by Type (2020-2025) & (K Units)
Table 178. Asia-Pacific HIV Therapy Drug Sales Quantity by Type (2026-2031) & (K Units)
Table 179. Asia-Pacific HIV Therapy Drug Sales Quantity by Application (2020-2025) & (K Units)
Table 180. Asia-Pacific HIV Therapy Drug Sales Quantity by Application (2026-2031) & (K Units)
Table 181. Asia-Pacific HIV Therapy Drug Sales Quantity by Region (2020-2025) & (K Units)
Table 182. Asia-Pacific HIV Therapy Drug Sales Quantity by Region (2026-2031) & (K Units)
Table 183. Asia-Pacific HIV Therapy Drug Consumption Value by Region (2020-2025) & (USD Million)
Table 184. Asia-Pacific HIV Therapy Drug Consumption Value by Region (2026-2031) & (USD Million)
Table 185. South America HIV Therapy Drug Sales Quantity by Type (2020-2025) & (K Units)
Table 186. South America HIV Therapy Drug Sales Quantity by Type (2026-2031) & (K Units)
Table 187. South America HIV Therapy Drug Sales Quantity by Application (2020-2025) & (K Units)
Table 188. South America HIV Therapy Drug Sales Quantity by Application (2026-2031) & (K Units)
Table 189. South America HIV Therapy Drug Sales Quantity by Country (2020-2025) & (K Units)
Table 190. South America HIV Therapy Drug Sales Quantity by Country (2026-2031) & (K Units)
Table 191. South America HIV Therapy Drug Consumption Value by Country (2020-2025) & (USD Million)
Table 192. South America HIV Therapy Drug Consumption Value by Country (2026-2031) & (USD Million)
Table 193. Middle East & Africa HIV Therapy Drug Sales Quantity by Type (2020-2025) & (K Units)
Table 194. Middle East & Africa HIV Therapy Drug Sales Quantity by Type (2026-2031) & (K Units)
Table 195. Middle East & Africa HIV Therapy Drug Sales Quantity by Application (2020-2025) & (K Units)
Table 196. Middle East & Africa HIV Therapy Drug Sales Quantity by Application (2026-2031) & (K Units)
Table 197. Middle East & Africa HIV Therapy Drug Sales Quantity by Country (2020-2025) & (K Units)
Table 198. Middle East & Africa HIV Therapy Drug Sales Quantity by Country (2026-2031) & (K Units)
Table 199. Middle East & Africa HIV Therapy Drug Consumption Value by Country (2020-2025) & (USD Million)
Table 200. Middle East & Africa HIV Therapy Drug Consumption Value by Country (2026-2031) & (USD Million)
Table 201. HIV Therapy Drug Raw Material
Table 202. Key Manufacturers of HIV Therapy Drug Raw Materials
Table 203. HIV Therapy Drug Typical Distributors
Table 204. HIV Therapy Drug Typical Customers
LIST OF FIGURES
Figure 1. HIV Therapy Drug Picture
Figure 2. Global HIV Therapy Drug Revenue by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global HIV Therapy Drug Revenue Market Share by Type in 2024
Figure 4. Multi-Type Combined Drugs Examples
Figure 5. Nucleoside Reverse Transcription Enzyme Inhibitors Examples
Figure 6. Non-Nucleoside Reverse Transcription Enzyme Inhibitors Examples
Figure 7. Hiv Integrated Enzyme Chain Transfer Inhibitor Examples
Figure 8. Global HIV Therapy Drug Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 9. Global HIV Therapy Drug Revenue Market Share by Application in 2024
Figure 10. Hospital Examples
Figure 11. Clinic Examples
Figure 12. Pharmacy Examples
Figure 13. Global HIV Therapy Drug Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 14. Global HIV Therapy Drug Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 15. Global HIV Therapy Drug Sales Quantity (2020-2031) & (K Units)
Figure 16. Global HIV Therapy Drug Price (2020-2031) & (US$/Unit)
Figure 17. Global HIV Therapy Drug Sales Quantity Market Share by Manufacturer in 2024
Figure 18. Global HIV Therapy Drug Revenue Market Share by Manufacturer in 2024
Figure 19. Producer Shipments of HIV Therapy Drug by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 20. Top 3 HIV Therapy Drug Manufacturer (Revenue) Market Share in 2024
Figure 21. Top 6 HIV Therapy Drug Manufacturer (Revenue) Market Share in 2024
Figure 22. Global HIV Therapy Drug Sales Quantity Market Share by Region (2020-2031)
Figure 23. Global HIV Therapy Drug Consumption Value Market Share by Region (2020-2031)
Figure 24. North America HIV Therapy Drug Consumption Value (2020-2031) & (USD Million)
Figure 25. Europe HIV Therapy Drug Consumption Value (2020-2031) & (USD Million)
Figure 26. Asia-Pacific HIV Therapy Drug Consumption Value (2020-2031) & (USD Million)
Figure 27. South America HIV Therapy Drug Consumption Value (2020-2031) & (USD Million)
Figure 28. Middle East & Africa HIV Therapy Drug Consumption Value (2020-2031) & (USD Million)
Figure 29. Global HIV Therapy Drug Sales Quantity Market Share by Type (2020-2031)
Figure 30. Global HIV Therapy Drug Consumption Value Market Share by Type (2020-2031)
Figure 31. Global HIV Therapy Drug Average Price by Type (2020-2031) & (US$/Unit)
Figure 32. Global HIV Therapy Drug Sales Quantity Market Share by Application (2020-2031)
Figure 33. Global HIV Therapy Drug Revenue Market Share by Application (2020-2031)
Figure 34. Global HIV Therapy Drug Average Price by Application (2020-2031) & (US$/Unit)
Figure 35. North America HIV Therapy Drug Sales Quantity Market Share by Type (2020-2031)
Figure 36. North America HIV Therapy Drug Sales Quantity Market Share by Application (2020-2031)
Figure 37. North America HIV Therapy Drug Sales Quantity Market Share by Country (2020-2031)
Figure 38. North America HIV Therapy Drug Consumption Value Market Share by Country (2020-2031)
Figure 39. United States HIV Therapy Drug Consumption Value (2020-2031) & (USD Million)
Figure 40. Canada HIV Therapy Drug Consumption Value (2020-2031) & (USD Million)
Figure 41. Mexico HIV Therapy Drug Consumption Value (2020-2031) & (USD Million)
Figure 42. Europe HIV Therapy Drug Sales Quantity Market Share by Type (2020-2031)
Figure 43. Europe HIV Therapy Drug Sales Quantity Market Share by Application (2020-2031)
Figure 44. Europe HIV Therapy Drug Sales Quantity Market Share by Country (2020-2031)
Figure 45. Europe HIV Therapy Drug Consumption Value Market Share by Country (2020-2031)
Figure 46. Germany HIV Therapy Drug Consumption Value (2020-2031) & (USD Million)
Figure 47. France HIV Therapy Drug Consumption Value (2020-2031) & (USD Million)
Figure 48. United Kingdom HIV Therapy Drug Consumption Value (2020-2031) & (USD Million)
Figure 49. Russia HIV Therapy Drug Consumption Value (2020-2031) & (USD Million)
Figure 50. Italy HIV Therapy Drug Consumption Value (2020-2031) & (USD Million)
Figure 51. Asia-Pacific HIV Therapy Drug Sales Quantity Market Share by Type (2020-2031)
Figure 52. Asia-Pacific HIV Therapy Drug Sales Quantity Market Share by Application (2020-2031)
Figure 53. Asia-Pacific HIV Therapy Drug Sales Quantity Market Share by Region (2020-2031)
Figure 54. Asia-Pacific HIV Therapy Drug Consumption Value Market Share by Region (2020-2031)
Figure 55. China HIV Therapy Drug Consumption Value (2020-2031) & (USD Million)
Figure 56. Japan HIV Therapy Drug Consumption Value (2020-2031) & (USD Million)
Figure 57. South Korea HIV Therapy Drug Consumption Value (2020-2031) & (USD Million)
Figure 58. India HIV Therapy Drug Consumption Value (2020-2031) & (USD Million)
Figure 59. Southeast Asia HIV Therapy Drug Consumption Value (2020-2031) & (USD Million)
Figure 60. Australia HIV Therapy Drug Consumption Value (2020-2031) & (USD Million)
Figure 61. South America HIV Therapy Drug Sales Quantity Market Share by Type (2020-2031)
Figure 62. South America HIV Therapy Drug Sales Quantity Market Share by Application (2020-2031)
Figure 63. South America HIV Therapy Drug Sales Quantity Market Share by Country (2020-2031)
Figure 64. South America HIV Therapy Drug Consumption Value Market Share by Country (2020-2031)
Figure 65. Brazil HIV Therapy Drug Consumption Value (2020-2031) & (USD Million)
Figure 66. Argentina HIV Therapy Drug Consumption Value (2020-2031) & (USD Million)
Figure 67. Middle East & Africa HIV Therapy Drug Sales Quantity Market Share by Type (2020-2031)
Figure 68. Middle East & Africa HIV Therapy Drug Sales Quantity Market Share by Application (2020-2031)
Figure 69. Middle East & Africa HIV Therapy Drug Sales Quantity Market Share by Country (2020-2031)
Figure 70. Middle East & Africa HIV Therapy Drug Consumption Value Market Share by Country (2020-2031)
Figure 71. Turkey HIV Therapy Drug Consumption Value (2020-2031) & (USD Million)
Figure 72. Egypt HIV Therapy Drug Consumption Value (2020-2031) & (USD Million)
Figure 73. Saudi Arabia HIV Therapy Drug Consumption Value (2020-2031) & (USD Million)
Figure 74. South Africa HIV Therapy Drug Consumption Value (2020-2031) & (USD Million)
Figure 75. HIV Therapy Drug Market Drivers
Figure 76. HIV Therapy Drug Market Restraints
Figure 77. HIV Therapy Drug Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of HIV Therapy Drug in 2024
Figure 80. Manufacturing Process Analysis of HIV Therapy Drug
Figure 81. HIV Therapy Drug Industrial Chain
Figure 82. Sales Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
Table 1. Global HIV Therapy Drug Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global HIV Therapy Drug Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. ViiV Healthcare Basic Information, Manufacturing Base and Competitors
Table 4. ViiV Healthcare Major Business
Table 5. ViiV Healthcare HIV Therapy Drug Product and Services
Table 6. ViiV Healthcare HIV Therapy Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. ViiV Healthcare Recent Developments/Updates
Table 8. Gilead Sciences, Inc Basic Information, Manufacturing Base and Competitors
Table 9. Gilead Sciences, Inc Major Business
Table 10. Gilead Sciences, Inc HIV Therapy Drug Product and Services
Table 11. Gilead Sciences, Inc HIV Therapy Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. Gilead Sciences, Inc Recent Developments/Updates
Table 13. AbbVie Inc. Basic Information, Manufacturing Base and Competitors
Table 14. AbbVie Inc. Major Business
Table 15. AbbVie Inc. HIV Therapy Drug Product and Services
Table 16. AbbVie Inc. HIV Therapy Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. AbbVie Inc. Recent Developments/Updates
Table 18. Merck & Co Basic Information, Manufacturing Base and Competitors
Table 19. Merck & Co Major Business
Table 20. Merck & Co HIV Therapy Drug Product and Services
Table 21. Merck & Co HIV Therapy Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. Merck & Co Recent Developments/Updates
Table 23. GSK Basic Information, Manufacturing Base and Competitors
Table 24. GSK Major Business
Table 25. GSK HIV Therapy Drug Product and Services
Table 26. GSK HIV Therapy Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. GSK Recent Developments/Updates
Table 28. Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table 29. Bristol-Myers Squibb Company Major Business
Table 30. Bristol-Myers Squibb Company HIV Therapy Drug Product and Services
Table 31. Bristol-Myers Squibb Company HIV Therapy Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. Bristol-Myers Squibb Company Recent Developments/Updates
Table 33. Theratechnologies Inc. Basic Information, Manufacturing Base and Competitors
Table 34. Theratechnologies Inc. Major Business
Table 35. Theratechnologies Inc. HIV Therapy Drug Product and Services
Table 36. Theratechnologies Inc. HIV Therapy Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 37. Theratechnologies Inc. Recent Developments/Updates
Table 38. Roche Holding AG Basic Information, Manufacturing Base and Competitors
Table 39. Roche Holding AG Major Business
Table 40. Roche Holding AG HIV Therapy Drug Product and Services
Table 41. Roche Holding AG HIV Therapy Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 42. Roche Holding AG Recent Developments/Updates
Table 43. Teva Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 44. Teva Pharmaceuticals Major Business
Table 45. Teva Pharmaceuticals HIV Therapy Drug Product and Services
Table 46. Teva Pharmaceuticals HIV Therapy Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 47. Teva Pharmaceuticals Recent Developments/Updates
Table 48. Pfizer Basic Information, Manufacturing Base and Competitors
Table 49. Pfizer Major Business
Table 50. Pfizer HIV Therapy Drug Product and Services
Table 51. Pfizer HIV Therapy Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 52. Pfizer Recent Developments/Updates
Table 53. Frontier Biotechnologies Basic Information, Manufacturing Base and Competitors
Table 54. Frontier Biotechnologies Major Business
Table 55. Frontier Biotechnologies HIV Therapy Drug Product and Services
Table 56. Frontier Biotechnologies HIV Therapy Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 57. Frontier Biotechnologies Recent Developments/Updates
Table 58. Shionogi Basic Information, Manufacturing Base and Competitors
Table 59. Shionogi Major Business
Table 60. Shionogi HIV Therapy Drug Product and Services
Table 61. Shionogi HIV Therapy Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 62. Shionogi Recent Developments/Updates
Table 63. Janssen Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 64. Janssen Pharmaceuticals, Inc. Major Business
Table 65. Janssen Pharmaceuticals, Inc. HIV Therapy Drug Product and Services
Table 66. Janssen Pharmaceuticals, Inc. HIV Therapy Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 67. Janssen Pharmaceuticals, Inc. Recent Developments/Updates
Table 68. Mylan Pharmaceuticals Inc. Basic Information, Manufacturing Base and Competitors
Table 69. Mylan Pharmaceuticals Inc. Major Business
Table 70. Mylan Pharmaceuticals Inc. HIV Therapy Drug Product and Services
Table 71. Mylan Pharmaceuticals Inc. HIV Therapy Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 72. Mylan Pharmaceuticals Inc. Recent Developments/Updates
Table 73. Genentech, Inc. Basic Information, Manufacturing Base and Competitors
Table 74. Genentech, Inc. Major Business
Table 75. Genentech, Inc. HIV Therapy Drug Product and Services
Table 76. Genentech, Inc. HIV Therapy Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 77. Genentech, Inc. Recent Developments/Updates
Table 78. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 79. Boehringer Ingelheim Major Business
Table 80. Boehringer Ingelheim HIV Therapy Drug Product and Services
Table 81. Boehringer Ingelheim HIV Therapy Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 82. Boehringer Ingelheim Recent Developments/Updates
Table 83. Cipla Basic Information, Manufacturing Base and Competitors
Table 84. Cipla Major Business
Table 85. Cipla HIV Therapy Drug Product and Services
Table 86. Cipla HIV Therapy Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 87. Cipla Recent Developments/Updates
Table 88. MSD Basic Information, Manufacturing Base and Competitors
Table 89. MSD Major Business
Table 90. MSD HIV Therapy Drug Product and Services
Table 91. MSD HIV Therapy Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 92. MSD Recent Developments/Updates
Table 93. Abbott Basic Information, Manufacturing Base and Competitors
Table 94. Abbott Major Business
Table 95. Abbott HIV Therapy Drug Product and Services
Table 96. Abbott HIV Therapy Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 97. Abbott Recent Developments/Updates
Table 98. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 99. Johnson & Johnson Major Business
Table 100. Johnson & Johnson HIV Therapy Drug Product and Services
Table 101. Johnson & Johnson HIV Therapy Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 102. Johnson & Johnson Recent Developments/Updates
Table 103. Biocon Limited Basic Information, Manufacturing Base and Competitors
Table 104. Biocon Limited Major Business
Table 105. Biocon Limited HIV Therapy Drug Product and Services
Table 106. Biocon Limited HIV Therapy Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 107. Biocon Limited Recent Developments/Updates
Table 108. Affine Formulations Limited Basic Information, Manufacturing Base and Competitors
Table 109. Affine Formulations Limited Major Business
Table 110. Affine Formulations Limited HIV Therapy Drug Product and Services
Table 111. Affine Formulations Limited HIV Therapy Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 112. Affine Formulations Limited Recent Developments/Updates
Table 113. IPCA Laboratories Basic Information, Manufacturing Base and Competitors
Table 114. IPCA Laboratories Major Business
Table 115. IPCA Laboratories HIV Therapy Drug Product and Services
Table 116. IPCA Laboratories HIV Therapy Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 117. IPCA Laboratories Recent Developments/Updates
Table 118. Natco Pharma Basic Information, Manufacturing Base and Competitors
Table 119. Natco Pharma Major Business
Table 120. Natco Pharma HIV Therapy Drug Product and Services
Table 121. Natco Pharma HIV Therapy Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 122. Natco Pharma Recent Developments/Updates
Table 123. Beacon Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 124. Beacon Pharmaceuticals Major Business
Table 125. Beacon Pharmaceuticals HIV Therapy Drug Product and Services
Table 126. Beacon Pharmaceuticals HIV Therapy Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 127. Beacon Pharmaceuticals Recent Developments/Updates
Table 128. Julphar Bangladesh Basic Information, Manufacturing Base and Competitors
Table 129. Julphar Bangladesh Major Business
Table 130. Julphar Bangladesh HIV Therapy Drug Product and Services
Table 131. Julphar Bangladesh HIV Therapy Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 132. Julphar Bangladesh Recent Developments/Updates
Table 133. Global HIV Therapy Drug Sales Quantity by Manufacturer (2020-2025) & (K Units)
Table 134. Global HIV Therapy Drug Revenue by Manufacturer (2020-2025) & (USD Million)
Table 135. Global HIV Therapy Drug Average Price by Manufacturer (2020-2025) & (US$/Unit)
Table 136. Market Position of Manufacturers in HIV Therapy Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 137. Head Office and HIV Therapy Drug Production Site of Key Manufacturer
Table 138. HIV Therapy Drug Market: Company Product Type Footprint
Table 139. HIV Therapy Drug Market: Company Product Application Footprint
Table 140. HIV Therapy Drug New Market Entrants and Barriers to Market Entry
Table 141. HIV Therapy Drug Mergers, Acquisition, Agreements, and Collaborations
Table 142. Global HIV Therapy Drug Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 143. Global HIV Therapy Drug Sales Quantity by Region (2020-2025) & (K Units)
Table 144. Global HIV Therapy Drug Sales Quantity by Region (2026-2031) & (K Units)
Table 145. Global HIV Therapy Drug Consumption Value by Region (2020-2025) & (USD Million)
Table 146. Global HIV Therapy Drug Consumption Value by Region (2026-2031) & (USD Million)
Table 147. Global HIV Therapy Drug Average Price by Region (2020-2025) & (US$/Unit)
Table 148. Global HIV Therapy Drug Average Price by Region (2026-2031) & (US$/Unit)
Table 149. Global HIV Therapy Drug Sales Quantity by Type (2020-2025) & (K Units)
Table 150. Global HIV Therapy Drug Sales Quantity by Type (2026-2031) & (K Units)
Table 151. Global HIV Therapy Drug Consumption Value by Type (2020-2025) & (USD Million)
Table 152. Global HIV Therapy Drug Consumption Value by Type (2026-2031) & (USD Million)
Table 153. Global HIV Therapy Drug Average Price by Type (2020-2025) & (US$/Unit)
Table 154. Global HIV Therapy Drug Average Price by Type (2026-2031) & (US$/Unit)
Table 155. Global HIV Therapy Drug Sales Quantity by Application (2020-2025) & (K Units)
Table 156. Global HIV Therapy Drug Sales Quantity by Application (2026-2031) & (K Units)
Table 157. Global HIV Therapy Drug Consumption Value by Application (2020-2025) & (USD Million)
Table 158. Global HIV Therapy Drug Consumption Value by Application (2026-2031) & (USD Million)
Table 159. Global HIV Therapy Drug Average Price by Application (2020-2025) & (US$/Unit)
Table 160. Global HIV Therapy Drug Average Price by Application (2026-2031) & (US$/Unit)
Table 161. North America HIV Therapy Drug Sales Quantity by Type (2020-2025) & (K Units)
Table 162. North America HIV Therapy Drug Sales Quantity by Type (2026-2031) & (K Units)
Table 163. North America HIV Therapy Drug Sales Quantity by Application (2020-2025) & (K Units)
Table 164. North America HIV Therapy Drug Sales Quantity by Application (2026-2031) & (K Units)
Table 165. North America HIV Therapy Drug Sales Quantity by Country (2020-2025) & (K Units)
Table 166. North America HIV Therapy Drug Sales Quantity by Country (2026-2031) & (K Units)
Table 167. North America HIV Therapy Drug Consumption Value by Country (2020-2025) & (USD Million)
Table 168. North America HIV Therapy Drug Consumption Value by Country (2026-2031) & (USD Million)
Table 169. Europe HIV Therapy Drug Sales Quantity by Type (2020-2025) & (K Units)
Table 170. Europe HIV Therapy Drug Sales Quantity by Type (2026-2031) & (K Units)
Table 171. Europe HIV Therapy Drug Sales Quantity by Application (2020-2025) & (K Units)
Table 172. Europe HIV Therapy Drug Sales Quantity by Application (2026-2031) & (K Units)
Table 173. Europe HIV Therapy Drug Sales Quantity by Country (2020-2025) & (K Units)
Table 174. Europe HIV Therapy Drug Sales Quantity by Country (2026-2031) & (K Units)
Table 175. Europe HIV Therapy Drug Consumption Value by Country (2020-2025) & (USD Million)
Table 176. Europe HIV Therapy Drug Consumption Value by Country (2026-2031) & (USD Million)
Table 177. Asia-Pacific HIV Therapy Drug Sales Quantity by Type (2020-2025) & (K Units)
Table 178. Asia-Pacific HIV Therapy Drug Sales Quantity by Type (2026-2031) & (K Units)
Table 179. Asia-Pacific HIV Therapy Drug Sales Quantity by Application (2020-2025) & (K Units)
Table 180. Asia-Pacific HIV Therapy Drug Sales Quantity by Application (2026-2031) & (K Units)
Table 181. Asia-Pacific HIV Therapy Drug Sales Quantity by Region (2020-2025) & (K Units)
Table 182. Asia-Pacific HIV Therapy Drug Sales Quantity by Region (2026-2031) & (K Units)
Table 183. Asia-Pacific HIV Therapy Drug Consumption Value by Region (2020-2025) & (USD Million)
Table 184. Asia-Pacific HIV Therapy Drug Consumption Value by Region (2026-2031) & (USD Million)
Table 185. South America HIV Therapy Drug Sales Quantity by Type (2020-2025) & (K Units)
Table 186. South America HIV Therapy Drug Sales Quantity by Type (2026-2031) & (K Units)
Table 187. South America HIV Therapy Drug Sales Quantity by Application (2020-2025) & (K Units)
Table 188. South America HIV Therapy Drug Sales Quantity by Application (2026-2031) & (K Units)
Table 189. South America HIV Therapy Drug Sales Quantity by Country (2020-2025) & (K Units)
Table 190. South America HIV Therapy Drug Sales Quantity by Country (2026-2031) & (K Units)
Table 191. South America HIV Therapy Drug Consumption Value by Country (2020-2025) & (USD Million)
Table 192. South America HIV Therapy Drug Consumption Value by Country (2026-2031) & (USD Million)
Table 193. Middle East & Africa HIV Therapy Drug Sales Quantity by Type (2020-2025) & (K Units)
Table 194. Middle East & Africa HIV Therapy Drug Sales Quantity by Type (2026-2031) & (K Units)
Table 195. Middle East & Africa HIV Therapy Drug Sales Quantity by Application (2020-2025) & (K Units)
Table 196. Middle East & Africa HIV Therapy Drug Sales Quantity by Application (2026-2031) & (K Units)
Table 197. Middle East & Africa HIV Therapy Drug Sales Quantity by Country (2020-2025) & (K Units)
Table 198. Middle East & Africa HIV Therapy Drug Sales Quantity by Country (2026-2031) & (K Units)
Table 199. Middle East & Africa HIV Therapy Drug Consumption Value by Country (2020-2025) & (USD Million)
Table 200. Middle East & Africa HIV Therapy Drug Consumption Value by Country (2026-2031) & (USD Million)
Table 201. HIV Therapy Drug Raw Material
Table 202. Key Manufacturers of HIV Therapy Drug Raw Materials
Table 203. HIV Therapy Drug Typical Distributors
Table 204. HIV Therapy Drug Typical Customers
LIST OF FIGURES
Figure 1. HIV Therapy Drug Picture
Figure 2. Global HIV Therapy Drug Revenue by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global HIV Therapy Drug Revenue Market Share by Type in 2024
Figure 4. Multi-Type Combined Drugs Examples
Figure 5. Nucleoside Reverse Transcription Enzyme Inhibitors Examples
Figure 6. Non-Nucleoside Reverse Transcription Enzyme Inhibitors Examples
Figure 7. Hiv Integrated Enzyme Chain Transfer Inhibitor Examples
Figure 8. Global HIV Therapy Drug Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 9. Global HIV Therapy Drug Revenue Market Share by Application in 2024
Figure 10. Hospital Examples
Figure 11. Clinic Examples
Figure 12. Pharmacy Examples
Figure 13. Global HIV Therapy Drug Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 14. Global HIV Therapy Drug Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 15. Global HIV Therapy Drug Sales Quantity (2020-2031) & (K Units)
Figure 16. Global HIV Therapy Drug Price (2020-2031) & (US$/Unit)
Figure 17. Global HIV Therapy Drug Sales Quantity Market Share by Manufacturer in 2024
Figure 18. Global HIV Therapy Drug Revenue Market Share by Manufacturer in 2024
Figure 19. Producer Shipments of HIV Therapy Drug by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 20. Top 3 HIV Therapy Drug Manufacturer (Revenue) Market Share in 2024
Figure 21. Top 6 HIV Therapy Drug Manufacturer (Revenue) Market Share in 2024
Figure 22. Global HIV Therapy Drug Sales Quantity Market Share by Region (2020-2031)
Figure 23. Global HIV Therapy Drug Consumption Value Market Share by Region (2020-2031)
Figure 24. North America HIV Therapy Drug Consumption Value (2020-2031) & (USD Million)
Figure 25. Europe HIV Therapy Drug Consumption Value (2020-2031) & (USD Million)
Figure 26. Asia-Pacific HIV Therapy Drug Consumption Value (2020-2031) & (USD Million)
Figure 27. South America HIV Therapy Drug Consumption Value (2020-2031) & (USD Million)
Figure 28. Middle East & Africa HIV Therapy Drug Consumption Value (2020-2031) & (USD Million)
Figure 29. Global HIV Therapy Drug Sales Quantity Market Share by Type (2020-2031)
Figure 30. Global HIV Therapy Drug Consumption Value Market Share by Type (2020-2031)
Figure 31. Global HIV Therapy Drug Average Price by Type (2020-2031) & (US$/Unit)
Figure 32. Global HIV Therapy Drug Sales Quantity Market Share by Application (2020-2031)
Figure 33. Global HIV Therapy Drug Revenue Market Share by Application (2020-2031)
Figure 34. Global HIV Therapy Drug Average Price by Application (2020-2031) & (US$/Unit)
Figure 35. North America HIV Therapy Drug Sales Quantity Market Share by Type (2020-2031)
Figure 36. North America HIV Therapy Drug Sales Quantity Market Share by Application (2020-2031)
Figure 37. North America HIV Therapy Drug Sales Quantity Market Share by Country (2020-2031)
Figure 38. North America HIV Therapy Drug Consumption Value Market Share by Country (2020-2031)
Figure 39. United States HIV Therapy Drug Consumption Value (2020-2031) & (USD Million)
Figure 40. Canada HIV Therapy Drug Consumption Value (2020-2031) & (USD Million)
Figure 41. Mexico HIV Therapy Drug Consumption Value (2020-2031) & (USD Million)
Figure 42. Europe HIV Therapy Drug Sales Quantity Market Share by Type (2020-2031)
Figure 43. Europe HIV Therapy Drug Sales Quantity Market Share by Application (2020-2031)
Figure 44. Europe HIV Therapy Drug Sales Quantity Market Share by Country (2020-2031)
Figure 45. Europe HIV Therapy Drug Consumption Value Market Share by Country (2020-2031)
Figure 46. Germany HIV Therapy Drug Consumption Value (2020-2031) & (USD Million)
Figure 47. France HIV Therapy Drug Consumption Value (2020-2031) & (USD Million)
Figure 48. United Kingdom HIV Therapy Drug Consumption Value (2020-2031) & (USD Million)
Figure 49. Russia HIV Therapy Drug Consumption Value (2020-2031) & (USD Million)
Figure 50. Italy HIV Therapy Drug Consumption Value (2020-2031) & (USD Million)
Figure 51. Asia-Pacific HIV Therapy Drug Sales Quantity Market Share by Type (2020-2031)
Figure 52. Asia-Pacific HIV Therapy Drug Sales Quantity Market Share by Application (2020-2031)
Figure 53. Asia-Pacific HIV Therapy Drug Sales Quantity Market Share by Region (2020-2031)
Figure 54. Asia-Pacific HIV Therapy Drug Consumption Value Market Share by Region (2020-2031)
Figure 55. China HIV Therapy Drug Consumption Value (2020-2031) & (USD Million)
Figure 56. Japan HIV Therapy Drug Consumption Value (2020-2031) & (USD Million)
Figure 57. South Korea HIV Therapy Drug Consumption Value (2020-2031) & (USD Million)
Figure 58. India HIV Therapy Drug Consumption Value (2020-2031) & (USD Million)
Figure 59. Southeast Asia HIV Therapy Drug Consumption Value (2020-2031) & (USD Million)
Figure 60. Australia HIV Therapy Drug Consumption Value (2020-2031) & (USD Million)
Figure 61. South America HIV Therapy Drug Sales Quantity Market Share by Type (2020-2031)
Figure 62. South America HIV Therapy Drug Sales Quantity Market Share by Application (2020-2031)
Figure 63. South America HIV Therapy Drug Sales Quantity Market Share by Country (2020-2031)
Figure 64. South America HIV Therapy Drug Consumption Value Market Share by Country (2020-2031)
Figure 65. Brazil HIV Therapy Drug Consumption Value (2020-2031) & (USD Million)
Figure 66. Argentina HIV Therapy Drug Consumption Value (2020-2031) & (USD Million)
Figure 67. Middle East & Africa HIV Therapy Drug Sales Quantity Market Share by Type (2020-2031)
Figure 68. Middle East & Africa HIV Therapy Drug Sales Quantity Market Share by Application (2020-2031)
Figure 69. Middle East & Africa HIV Therapy Drug Sales Quantity Market Share by Country (2020-2031)
Figure 70. Middle East & Africa HIV Therapy Drug Consumption Value Market Share by Country (2020-2031)
Figure 71. Turkey HIV Therapy Drug Consumption Value (2020-2031) & (USD Million)
Figure 72. Egypt HIV Therapy Drug Consumption Value (2020-2031) & (USD Million)
Figure 73. Saudi Arabia HIV Therapy Drug Consumption Value (2020-2031) & (USD Million)
Figure 74. South Africa HIV Therapy Drug Consumption Value (2020-2031) & (USD Million)
Figure 75. HIV Therapy Drug Market Drivers
Figure 76. HIV Therapy Drug Market Restraints
Figure 77. HIV Therapy Drug Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of HIV Therapy Drug in 2024
Figure 80. Manufacturing Process Analysis of HIV Therapy Drug
Figure 81. HIV Therapy Drug Industrial Chain
Figure 82. Sales Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
